Impact of 2013 ASCO/CAP HER2 Guideline Updates at an Academic Medical Center That Performs Primary HER2 FISH Testing: Increase in Equivocal Results and Utility of Reflex Immunohistochemistry

被引:0
|
作者
Muller, Kristen [1 ]
Tafe, Laura [1 ]
Steinmetz, Heather [1 ]
Marotti, Jonathan [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
215
引用
收藏
页码:57A / 57A
页数:1
相关论文
共 50 条
  • [21] New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers
    N. Tchrakian
    L. Flanagan
    J. Harford
    J. M. Gannon
    C. M. Quinn
    Virchows Archiv, 2016, 468 : 207 - 211
  • [22] Impact of the 2013 ASCO/CAP Guideline Recommendations for HER2Testing of Invasive Breast Carcinoma: A Focus on Tumors Assessed as Equivocal for HER2 Gene Amplification By FISH
    Bethune, Gillian
    van Zanten, Daniel Veldheijzen
    Younis, Tallal
    Rayson, Daniel
    Thompson, Kara
    Barnes, Penny
    LABORATORY INVESTIGATION, 2015, 95 : 35A - 35A
  • [23] New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers
    Tchrakian, N.
    Flanagan, L.
    Harford, J.
    Gannon, J. M.
    Quinn, C. M.
    VIRCHOWS ARCHIV, 2016, 468 (02) : 207 - 211
  • [24] Determination of FISH Her2 testing: Comparing the ASCO/CAP guideline and CAP expert panel guideline
    Vinyuvat, S.
    Pongampan, P.
    Samarnthai, N.
    Suthipintawong, C.
    HISTOPATHOLOGY, 2012, 61 : 32 - 33
  • [25] HER2 targeted therapy and outcome in HER2equivocal cases after 2018 ASCO/CAP HER2 guideline modification
    Crespo, James
    Sun, Hongxia
    Wu, Jimin
    Ding, Qingqing
    Tang, Guilin
    Robinson, Melissa
    Chen, Hui
    Sahin, Aysegul A.
    Lim, Bora
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] The Impact of 2013 ASCO/CAP Guidelines on the Breast Cancer Her2/Neu FISH Results
    Zhang, Songlin
    Wang, Xiaohong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S144 - S144
  • [27] The Impact of 2013 Updated ASCO/CAP HER2 Guideline on the Diagnosis and Management of HER2 Positive Breast Cancer: A Single Center Retrospective Study
    Zhang, Xiaofei
    Jaffer, Shabnam
    Bleiweiss, Ira
    Nayak, Anupma
    MODERN PATHOLOGY, 2015, 28 : 75A - 75A
  • [28] The Impact of 2013 Updated ASCO/CAP HER2 Guideline on the Diagnosis and Management of HER2 Positive Breast Cancer: A Single Center Retrospective Study
    Zhang, Xiaofei
    Jaffer, Shabnam
    Bleiweiss, Ira
    Nayak, Anupma
    LABORATORY INVESTIGATION, 2015, 95 : 75A - 75A
  • [29] Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+Invasive Breast Cancer
    Yamada, Mai
    Kubo, Makoto
    Yamamoto, Hidetaka
    Yamashita, Nami
    Kai, Masaya
    Zaguirre, Karen
    Kaneshiro, Kazuhisa
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Mori, Masaki
    Oda, Yoshinao
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2021, 41 (08) : 4143 - 4149
  • [30] Evaluation of the Clinical Implementation of the 2013 CAP/ASCO HER2 FISH Testing Guidelines
    Kang, S. -H. L.
    Lillemoe, T. J.
    Grimm, E. V.
    Susnik, B.
    Swenson, K. K.
    Tsai, M. L.
    CYTOGENETIC AND GENOME RESEARCH, 2014, 142 (03)